Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

BeiGene PD-(L)1 Inhibitor Approved in US for Esophageal Carcinoma

KeChow Approved to Launch Tunlametinib for Melanoma Patients in China

Aslan Pharma Offers Data Showing Eblasakimab Effective in COPD

Ranok to Start China Trial of Protein Degrader for Solid Tumors and Lymphomas

RemeGen Says anti-HER2 ADC Effective for Cervical Cancer

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital